{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:01:47Z","timestamp":1785441707284,"version":"3.56.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.transci.2026.104453","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:02:59Z","timestamp":1780300979000},"page":"104453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relapsed thrombotic thrombocytopenic purpura and daratumumab utility"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-0325","authenticated-orcid":false,"given":"Maria Eduarda","family":"Couto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tikka","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104453_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.19026","article-title":"A British society for haematology guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies","volume":"203","author":"Scully","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2026.104453_bib2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.2020009150","article-title":"Redefining outcomes in immune TTP: an international working group consensus report","volume":"137","author":"Cuker","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.transci.2026.104453_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.transci.2026.104453_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transci.2026.104453_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003604","article-title":"Daratumumab for autoimmune diseases: a systematic review","volume":"9","author":"Holzer","year":"2023","journal-title":"RMD Open"},{"issue":"11","key":"10.1016\/j.transci.2026.104453_bib6","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1111\/jth.15027","article-title":"Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura","volume":"18","author":"Tse","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.transci.2026.104453_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/bloodadvances.2025017279","article-title":"Safety and efficacy of daratumumab in immune thrombocytopenia","volume":"10","author":"Tsykunova","year":"2026","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.transci.2026.104453_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2026.103405","article-title":"Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up","volume":"10","author":"Schimmer","year":"2026","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.transci.2026.104453_bib9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1182\/bloodadvances.2021005124","article-title":"Daratumumab for immune thrombotic thrombocytopenic purpura","volume":"6","author":"Van der Berg","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.transci.2026.104453_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/bjh.18854","article-title":"Daratumumab for refractory immune- mediated thrombotic thrombocytopenic purpura","volume":"202","author":"Aggarwal","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2026.104453_bib11","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1182\/blood-2025-4883","article-title":"Daratumumab for immune-mediated thrombotic thrombocytopenic purpura (iTTP): results from the international, multicenter darttp study","volume":"146","author":"Giannotta","year":"2025","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2026.104453_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4103\/ijn.IJN_236_20","article-title":"Thrombotic thrombocytopenic purpura and ulcerative colitis - a potential link revisited","author":"Gaur","year":"2021","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.transci.2026.104453_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00004836-200103000-00016","article-title":"Ulcerative colitis and thrombotic thrombocytopenic purpura","volume":"32","author":"Almogy","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.transci.2026.104453_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jca.10037","article-title":"First two patients with Ulcerative colitis who developed classical thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange","volume":"17","author":"Baron","year":"2002","journal-title":"J Clin Apher"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:30:19Z","timestamp":1785439819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1473050226000856"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104453","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relapsed thrombotic thrombocytopenic purpura and daratumumab utility","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104453"}}